The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively.

(RTTNews) - United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application ...

United Therapeutics (UTHR) announced that the FDA has cleared its investigational new drug application to initiate a clinical study of the company’s investigational UKidney derived from a 10 ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., February 03, 2025--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application ...

It's as significant for the medical community as it is for the local business. Silver Spring’s United Therapeutics Corp. (NASDAQ: UTHR) has scored a regulatory green light to start clinical ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. - United Therapeutics (NASDAQ:UTHR) Corporation (NASDAQ: UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a ...

This expansion aims to meet the growing demand for specialty enzymes in diagnostics and therapeutics ... Funding: In the United States, the NIH allocated over $42.0 billion for biomedical research ...

United Therapeutics said Monday that the Food and Drug Administration has cleared it to begin the first clinical trial testing whether organs from gene-edited pigs could provide a viable option ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. - United Therapeutics (NASDAQ:UTHR) Corporation (NASDAQ: UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a ...